Wonju Severance Christian Hospital

The trials here

What the 48 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease15 trials
• Atrial fibrillation4 trials
• Chronic kidney disease4 trials
• Ulcerative colitis4 trials
• High blood pressure3 trials
• Heart failure2 trials
• Liver cirrhosis2 trials
• Obesity2 trials
• Type 2 diabetes2 trials
• Alzheimer disease1 trial
• Ankylosing spondylitis1 trial
• Crohn's disease1 trial
• and 10 more

Phase

• Phase 311 trials
• Phase 26 trials
• Phase 45 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Completed18 trials
• Recruiting13 trials
• Active, not recruiting11 trials
• Not yet recruiting3 trials
• Terminated2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Eli Lilly and Company5 trials
• Seung-Jung Park4 trials
• Samsung Medical Center3 trials
• Wonju Severance Christian Hospital3 trials
• Yuhan Corporation3 trials
• and 26 more

Running trials

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

  Contact: Hyun Soo Kim (principal investigator)

• Recruiting

  Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

  NCT07329699· Samsung Medical Center· Source

  Contact: Sung Gyun Ahn, MD, PhD

• Not yet recruiting

  Dronedarone Rhythm Intervention for Early Atrial Fibrillation

  NCT07270848· Phase 4· Inha University Hospital· Source

  Contact: Goeun Seol

• Enrolling by invitation

  QOL and Mental Health Using APD With Remote Monitoring System

  NCT07012499· Wonju Severance Christian Hospital· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Moon Young Kim (principal investigator)

• Recruiting

  Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)

  NCT07009418· Samsung Medical Center· Source

  Contact: Jung-Hee Lee, MD, PhD

• Recruiting

  Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

  NCT06962098· Phase 2· Aptabio Therapeutics, Inc.· Source

  Contact: Byoung Geun Han

• Active, not recruiting

  A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

  NCT06653153· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

  NCT06643819· Phase 3· Chong Kun Dang Pharmaceutical· Source

  Contact: Byungsu Yoo, PI

• Recruiting

  MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

  NCT06543082· Phase 4· CHA University· Source

  Contact: Joong-Hee Lee

• Recruiting

  A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

  NCT06246123· Eisai Korea Inc.· Source

  Contact: Serena SoYoun Kwon

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

  NCT06041529· Phase 4· Yuhan Corporation· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Drug-Coated Balloon in Patients With High Bleeding Risk

  NCT05221931· Samsung Medical Center· Source

• Active, not recruiting

  Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

  NCT06247280· Yuhan Corporation· Source

• Recruiting

  Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

  NCT06075433· Genoss Co., Ltd.· Source

  Contact: Young Jin youn

• Recruiting

  Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC

  NCT05093881· Pharmicell Co., Ltd.· Source

  Contact: Moonyoung Kim

• Recruiting

  Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

  NCT06075420· Genoss Co., Ltd.· Source

  Contact: Young Jin Youn

• Recruiting

  Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

  NCT04689152· Phase 3· Pharmicell Co., Ltd.· Source

  Contact: Moonyoung Kim

• Active, not recruiting

  Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

  NCT04585074· Severance Hospital· Source

• Active, not recruiting

  Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

  NCT03967158· Seung-Jung Park· Source

• Active, not recruiting

  Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

  NCT03315364· Phase 2/3· Daehwa Pharmaceutical Co., Ltd.· Source

• Active, not recruiting

  IRIS-Synergy Cohort in the IRIS-DES Registry

  NCT02720419· Jung-min Ahn· Source

• Recruiting

  Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study

  NCT02792075· Seung-Jung Park· Source

  Contact: Jung-han Yoon, MD

• Active, not recruiting

  IRIS-Onyx Cohort in the IRIS-DES Registry

  NCT02593994· Seung-Jung Park· Source

• Recruiting

  Gangwon PCI Prospective Registry

  NCT02038127· Yonsei University· Source

  Contact: Young Jin Youn, M.D., Ph.D.

• Recruiting

  Study of the Natural History of FFR Guided Percutaneous Coronary Intervention

  NCT01366404· Seung-Jung Park· Source

  Contact: Jung-han Yoon, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease8 recruiting
• Chronic kidney disease2 recruiting
• Liver cirrhosis2 recruiting
• Ulcerative colitis2 recruiting
• Atrial fibrillation1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• High blood pressure1 recruiting
• Rheumatoid arthritis1 recruiting

Closed trials

• Completed

  Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

  NCT06954766· Phase 2· Chong Kun Dang Pharmaceutical· Source

• Completed

  Taekwondo for Axial Spondyloarthritis

  NCT06823726· Wonju Severance Christian Hospital· Source

• Completed

  Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms

  NCT06734858· S-Alpha Therapeutics, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

  NCT07028697· Phase 3· Nxera Pharma Korea Co., Ltd.· Source

• Terminated

  REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

  NCT06237309· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

  NCT06249919· Phase 1/2· Neuracle Science Co., LTD.· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

  NCT05804747· Daiichi Sankyo· Source

• Completed

  Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

  NCT05718375· Phase 2· Curacle Co., Ltd.· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· Phase 3· Novo Nordisk A/S· Source

• Completed

  Carvedilol in HF With Preserved EF

  NCT05553314· Phase 4· Seoul National University Bundang Hospital· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Incyte Corporation· Source

• Completed

  Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

  NCT04607837· Phase 2· Pfizer· Source

• Completed

  Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

  NCT06293261· Yuhan Corporation· Source

• Completed

  A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

  NCT04799496· Takeda· Source

• Completed

  Resolution of Thrombi in Left Atrial Appendage With Edoxaban

  NCT03840291· Phase 4· Keimyung University Dongsan Medical Center· Source

• Completed

  Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

  NCT03611725· Wonju Severance Christian Hospital· Source

• Completed

  Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea

  NCT03288974· Celgene· Source

• Completed

  IRIS Ultimaster Cohort in the IRIS-DES Registry

  NCT02719106· Duk-Woo Park, MD· Source